EPS

Amid a complex healthcare market, The Ensign Group will outline its aggressive growth and operational playbook for investors at the upcoming Oppenheimer conference.

Strathcona Resources to repurchase up to 5% of its shares, calling them undervalued. The move signals strong confidence and boosts shareholder value.

BRC Group Holdings announced a major debt reduction, but a history of late filings, shareholder dilution, and high-risk bets cast a shadow on its recovery.

As Argan prepares its Q4 results, investors are watching if its record backlog and dual energy strategy can sustain its powerful year-end performance.

With its earnings call set for March 26, Designer Brands faces a crucial moment. Can its new strategies overcome a tough market and deliver on growth?

Psyence BioMed is building a pharmaceutical powerhouse by controlling its supply chain, a strategic move that could redefine the future of psychedelic medicine.

Following a major acquisition and the final Worldpay sale, the fintech giant’s upcoming presentation is a key event for investors watching its next move.

With $128.7M in cash and zero debt, Singapore's OMS Energy is leveraging its financial might and a key Saudi Aramco deal to dominate the oilfield market.

The spice maker's upcoming Q1 report will reveal if it can manage costs, sustain consumer demand, and deliver on its ambitious 2026 growth strategy.

As IZEA prepares its 2025 results, investors watch for signs of health in the booming but volatile influencer marketing industry it helped pioneer.

The industrial giant earns top global ESG ratings for the third straight year, proving that strategic sustainability drives both environmental impact and investor value.

The digital art firm secured new capital, but a severe market backlash raises questions about its strategy and path forward in the competitive NFT space.

A new survey finds companies are dynamically adjusting investment hurdles in response to market chaos, leveraging technology to navigate an uncertain world.

Amid historic defense budgets, COPT Defense heads to a key conference, poised to showcase its robust financial health and critical role in national security.

As electroCore preps its 2025 financial report, all eyes are on its product growth, the new Quell device, and its path to profitability in the booming bioelectronic market.

With record backlogs and surging demand from AI and energy transition, Quanta's March 31st event will reveal new targets shaping the future of infrastructure.

FinVolution Group is set to release its 2025 financials, with investors watching to see if international growth and AI tech can navigate market headwinds.

Magellan Aerospace holds its dividend steady, reflecting a strategy of balanced growth and shareholder return amid a recovering but challenged global market.

With key investor conferences ahead, Fiserv's leadership must convince Wall Street its costly strategic investments will pay off amid slowing growth.

Propelled by its teen-focused Journeys brand, the footwear retailer posted strong profits, navigating mixed results in other divisions and setting a path for 2027.